IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease.
Henden AS, Koyama M, Robb RJ, Forero A, Kuns RD, Chang K, Ensbey KS, Varelias A, Kazakoff SH, Waddell N, Clouston AD, Giri R, Begun J, Blazar BR, Degli-Esposti MA, Kotenko SV, Lane SW, Bowerman KL, Savan R, Hugenholtz P, Gartlan KH, Hill GR.
Blood. 2021 Aug 26;138(8):722-737. doi: 10.1182/blood.2020006375.
PMID: 34436524
